We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
Product defect recall alert for Folltropin 700 IU Powder and Solvent for Solution for Injection by Vetoquinol SA and Vetoquinol UK Limited.
Safety leaflet on epilepsy medicines and pregnancy to help patients and their families understanding the risks.
As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used
Guidance on the process for ending a clinical trial.
Information about the reproductive risks of taking valproate medicines and the measures in place to reduce potential harm.
Summary of the latest safety advice for medicines and medical device users
How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).